A06 Tri-complex Inhibitors of the Oncogenic, GTP-Bound Form of KRASG12C Overcome RTK-Mediated Escape Mechanisms and Drive Tumor Regressions in Preclinical Models of NSCLC
Year: 2020
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: R. Nichols, C. Schulze, A. Bermingham, T. Choy, J. Cregg, G. Kiss, A. Marquez, D. Reyes, M. Saldajeno-Concar, C. Weller, D. Whalen, Y. Yang, Z. Wang, E.S. Koltun, M. Singh, D. Wildes, A.L. Gill, R. Hansen, S. Kelsey, M. Goldsmith, J. Smith
Institution: Revolution Medicines (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W3001183380
